Protein Aggregation in Neurodegeneration

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 13-17

  Aguzzi, Adriano ^a   Kana, Veronika ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Amyloid; Amyloid fibril; Functional amyloids; Prionoids; Protein aggregation; Protein misfolding

Indexed keywords

EID: 84860333072     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch4     Document Type: Chapter

References (20)

1. Dobson C. Protein folding and misfolding. Nature 2003; 426: 884-890.
2. Luheshi L, Dobson C. Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett 2009; 583: 2581-2586.
3. Tartaglia G, Pawar A, Campioni S, Dobson C, Chiti F, Vendruscolo M. Prediction of aggregation-prone regions in structured proteins. J Mol Biol 2008; 380: 425-436.
4. Sawaya M, Sambashivan S, Nelson R, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007; 447: 453-457.
5. Nilsson K, Ikenberg K, Aslund A, et al. Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy. Am J Pathol 2010; 176: 563-574.
6. Goldschmidt L, Teng P, Riek R, Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA 2010; 107 (8): 3487-3492.
7. Westerman M, Cooper-Blacketer D, Mariash A, et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 2002; 22: 1858-1867.
8. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-175.
9. Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008; 372: 216-223.
10. Haass C, Selkoe D. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101-112.
11. Kayed R, Head E, Thompson J, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300: 486-489.
12. Meyer-Luehmann M, Spires-Jones T, Prada C, et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008; 451: 720-724.
13. Aguzzi A, Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 2004; 116: 313-327.
14. Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009; 64: 783-790.
15. Aguzzi A. Cell biology: beyond the prion principle. Nature 2009; 459: 924-925.
16. Halfmann R, Alberti S, Lindquist S. Prions, protein homeostasis, and phenotypic diversity. Trends Cell Biol 2010; 20(3): 125-133.
17. Si K, Choi Y, White-Grindley E, Majumdar A, Kandel E. Aplysia CPEB Can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 2010; 140: 421-435.
18. Badtke M, Hammer N, Chapman M. Functional amyloids signal their arrival. Sci Signal 2009; 2: 43.
19. Hurbain I, Geerts W, Boudier T, et al. Electron tomography of early melanosomes: implications for melanogenesis and the generation of fibrillar amyloid sheets. Proc Natl Acad Sci USA 2008; 105: 19726-19731.
20. Maji S, Perrin M, Sawaya M, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009; 325: 328-332.